))
Cardiorenal Collaboration: Optimizing Multidisciplinary Care in the CvRM Patient
Manage episode 457680409 series 3381434
A tartalmat a ReachMD biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a ReachMD vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
CME credits: 0.25
Valid until: 23-10-2025
Claim your CME credit at https://reachmd.com/programs/cme/cardiorenal-collaboration-optimizing-multidisciplinary-care-in-the-cvrm-patient/26667/
The outcomes of large clinical trials such as EMPA-REG have demonstrated that SGLT2 inhibitors are effective, but they do more than lower blood sugar and improve A1c. Similar to statins a long time ago, SGLT2 inhibitors offer many advantages for patients with potential atherosclerotic endpoints. Learn from our expert multidisciplinary panel as they explore the various approaches to treatment that can improve outcomes and quality of life in your patients with cardiorenal comorbidities.=
…
continue reading
Valid until: 23-10-2025
Claim your CME credit at https://reachmd.com/programs/cme/cardiorenal-collaboration-optimizing-multidisciplinary-care-in-the-cvrm-patient/26667/
The outcomes of large clinical trials such as EMPA-REG have demonstrated that SGLT2 inhibitors are effective, but they do more than lower blood sugar and improve A1c. Similar to statins a long time ago, SGLT2 inhibitors offer many advantages for patients with potential atherosclerotic endpoints. Learn from our expert multidisciplinary panel as they explore the various approaches to treatment that can improve outcomes and quality of life in your patients with cardiorenal comorbidities.=
455 epizódok
Megosztás
